Navigation Links
Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth
Date:10/5/2010

this regard, for Generex Oral-lyn™ as well as other diabetic and energy related pipeline products using the buccal delivery platform technologies.

The third prong to our strategy is to work with other pharmaceutical companies to establish the use of our proprietary liquid formulations that allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using our proprietary RapidMist™ device.  By using RapidMist™ as a delivery method, we believe we can extend the patent life of injectable drugs near the end of their patent protection, greatly enhancing the value of those drugs.

For our immunotherapeutic vaccine platform, under development at our wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), we are confident that fiscal 2011 will be a year of great advancement in these groundbreaking efforts.  We believe the vast potential of our breast, prostate, and other AE37 cancer vaccines are unmined gems for our Company.  AE37 is used to generate a specific immunological response to cancers expressing the HER2 oncogene.  We are in the midst of a Phase II clinical trial in patients with breast cancer and a Phase I trial in patients with ovarian cancer.  In addition, we recently completed a Phase I trial in patients with prostate cancer and are making preparations to move into a Phase II trial.  We anticipate our Phase II AE37 trial in breast cancer will be completed in fiscal 2011 and, provided that the study data is consistent with data available to date, we intend to work with the FDA on a plan to conduct a Phase III study for this important vaccine.

We have recently looked to augment our team of scientific advisors as we move our development programs and pipeline of products toward commercialization.  We intend to take advantage of their experience and expertise to assist our scientifi
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015  Astellas ... (CKF), is pleased to sponsor the second annual Bounce ... award, which will recognize two transplant recipients who exhibit ... a career accomplishment, participation in a sport or hobby, ... loved ones. "The Bounce Back Award ...
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Recent Highlights: Qutenza ® (capsaicin) ... adoption by large US institutions; 238 hospitals purchased as of 4Q10, ... Q4 2010 revenue totaled $2.3 million including $0.5 million U.S. Qutenza ... in 17 countries at December 31, 2010 NGX-1998 Phase 2 ...
... March 30, 2011 Rochester Medical Corporation (Nasdaq: ... BioSciences N.V. today approved the previously announced sale of ... subsidiary to Rochester Medical Corporation. Rochester Medical ... and under the terms of the Share Purchase Agreement ...
Cached Medicine Technology:NeurogesX Reports Fourth Quarter and Year-End 2010 Results 2NeurogesX Reports Fourth Quarter and Year-End 2010 Results 3NeurogesX Reports Fourth Quarter and Year-End 2010 Results 4NeurogesX Reports Fourth Quarter and Year-End 2010 Results 5NeurogesX Reports Fourth Quarter and Year-End 2010 Results 6NeurogesX Reports Fourth Quarter and Year-End 2010 Results 7NeurogesX Reports Fourth Quarter and Year-End 2010 Results 8NeurogesX Reports Fourth Quarter and Year-End 2010 Results 9Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation 2
(Date:4/1/2015)... April 01, 2015 New Jersey ... by other First Spouses from across the country ... March 21, 2015, World Down Syndrome Day(WDSD), to ... rapidly advancing area of Down syndrome cognition research. ... included Alabama, Alaska, American Samoa, Arizona, California, Colorado, ...
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), one ... a new app to keep health care providers informed ... C virus (HCV) infection. This ‘HCV Treatment Path’ app ... American Association for the Study of Liver Diseases (AASLD) ... oral medications to treat HCV have been approved by ...
(Date:4/1/2015)... 2015 Dr Roz Kamani, a Vancouver ... now offering her patients an opportunity to learn more ... in “Beauty Days”, which is an exclusive VIP event ... Kitsilano Skin Care Clinic. It is attended by Dr ... the latest products and services that are on offer. ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 South Florida’s ... Provisional Certificate of Authority (PCOA) approval from the State ... in the ongoing development of a retirement community that ... health, wellness and spiritual development. , America’s aging population ... meet the housing needs of seniors, according to a ...
(Date:4/1/2015)... PA (PRWEB) April 01, 2015 Health ... company and a subsidiary of West Corporation, today launched ... at http://blog.healthadvocate.com and through the Health Advocate ... healthcare consumers get, and stay, healthy. , “We’re pleased ... available to the public,” said Martin Rosen, Executive Vice ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... HMSY ) today announced that it will present at the William ... held June 9 - 11 at The Four Seasons Hotel in ... 10th at 4:00 p.m. CT. , , HMS Holdings ... integrity services for government healthcare programs. The Company,s clients include health ...
... 8, 2009 Ontario children are more likely to get ... of the Institute for Clinical Evaluative Sciences (ICES) has found ... of diabetes in Ontario children from 1994 to 2004. ... major health problems. Most children with diabetes have Type 1, ...
... study finds , MONDAY, June 8 (HealthDay News) -- ... the world,s most influential medical journals, a new study ... learning all they can about gender differences in response ... 661 prospective studies about types of cancer that afflict ...
... and Accountability in Kidney Care, to reduce mortality by 20 ... , , WASHINGTON, June 8 Kidney ... campaign pledging to reduce mortality among first-year dialysis patients -- ... the end of 2012. , , The ...
... , , Aspirin a Day, Other Services Cited ... WASHINGTON, June 8 As Congress tackles health reform, a new ... saved every year by investing in five basic preventive services. That ... who could benefit were advised by their doctors to take a ...
... and Rochester , ... According to New Reports from HealthLeaders-InterStudy , , ... managed care market intelligence, reports that medical home pilot initiatives ... determine whether such programs can save money by directing care ...
Cached Medicine News:Health News:Still Too Few Women in Cancer Trials 2Health News:Still Too Few Women in Cancer Trials 3Health News:Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients 2Health News:Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients 3Health News:U.S. Could Save 100,000 Lives a Year with Five Basic Preventive Services 2Health News:Medical Home Pilot Initiatives Continue to Expand Nationwide 2Health News:Medical Home Pilot Initiatives Continue to Expand Nationwide 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: